Vitamin E decreases bone mass by stimulating osteoclast fusion
- PMID: 22388090
- DOI: 10.1038/nm.2659
Vitamin E decreases bone mass by stimulating osteoclast fusion
Erratum in
- Nat Med. 2012 Sep;18(9):1445
Abstract
Bone homeostasis is maintained by the balance between osteoblastic bone formation and osteoclastic bone resorption. Osteoclasts are multinucleated cells that are formed by mononuclear preosteoclast fusion. Fat-soluble vitamins such as vitamin D are pivotal in maintaining skeletal integrity. However, the role of vitamin E in bone remodeling is unknown. Here, we show that mice deficient in α-tocopherol transfer protein (Ttpa(-/-) mice), a mouse model of genetic vitamin E deficiency, have high bone mass as a result of a decrease in bone resorption. Cell-based assays indicated that α-tocopherol stimulated osteoclast fusion, independent of its antioxidant capacity, by inducing the expression of dendritic-cell-specific transmembrane protein, an essential molecule for osteoclast fusion, through activation of mitogen-activated protein kinase 14 (p38) and microphthalmia-associated transcription factor, as well as its direct recruitment to the Tm7sf4 (a gene encoding DC-STAMP) promoter. Indeed, the bone abnormality seen in Ttpa(-/-) mice was rescued by a Tm7sf4 transgene. Moreover, wild-type mice or rats fed an α-tocopherol-supplemented diet, which contains a comparable amount of α-tocopherol to supplements consumed by many people, lost bone mass. These results show that serum vitamin E is a determinant of bone mass through its regulation of osteoclast fusion.
Comment in
-
Bone: Vitamin E: friend or foe to bone?Nat Rev Rheumatol. 2012 Mar 20;8(5):247. doi: 10.1038/nrrheum.2012.38. Nat Rev Rheumatol. 2012. PMID: 22434251 No abstract available.
-
Vitamin E: good for the heart, bad for the bones?Nat Med. 2012 Apr 5;18(4):491-2. doi: 10.1038/nm.2718. Nat Med. 2012. PMID: 22481404 No abstract available.
Similar articles
-
Vitamin E: good for the heart, bad for the bones?Nat Med. 2012 Apr 5;18(4):491-2. doi: 10.1038/nm.2718. Nat Med. 2012. PMID: 22481404 No abstract available.
-
Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.J Biol Chem. 2012 Jun 1;287(23):19229-41. doi: 10.1074/jbc.M111.323600. Epub 2012 Apr 12. J Biol Chem. 2012. PMID: 22500026 Free PMC article.
-
The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.J Exp Med. 2010 Apr 12;207(4):751-62. doi: 10.1084/jem.20091957. Epub 2010 Apr 5. J Exp Med. 2010. PMID: 20368579 Free PMC article.
-
Regulators of osteoclast differentiation and cell-cell fusion.Keio J Med. 2011;60(4):101-5. doi: 10.2302/kjm.60.101. Keio J Med. 2011. PMID: 22200633 Review.
-
The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity.Mod Rheumatol. 2006;16(6):341-2. doi: 10.1007/s10165-006-0524-0. Epub 2006 Dec 20. Mod Rheumatol. 2006. PMID: 17164993 Review.
Cited by
-
Vitamin E as an Antiosteoporotic Agent via Receptor Activator of Nuclear Factor Kappa-B Ligand Signaling Disruption: Current Evidence and Other Potential Research Areas.Evid Based Complement Alternat Med. 2012;2012:747020. doi: 10.1155/2012/747020. Epub 2012 Aug 2. Evid Based Complement Alternat Med. 2012. PMID: 22919420 Free PMC article.
-
Multi-functional osteoclasts in matrix-based tissue engineering bone.Chin J Traumatol. 2022 May;25(3):132-137. doi: 10.1016/j.cjtee.2021.11.003. Epub 2021 Nov 26. Chin J Traumatol. 2022. PMID: 34969539 Free PMC article. Review.
-
α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption.J Bone Metab. 2012 Nov;19(2):111-20. doi: 10.11005/jbm.2012.19.2.111. Epub 2012 Nov 16. J Bone Metab. 2012. PMID: 24524041 Free PMC article.
-
Partial Protection by Dietary Antioxidants Against Ethanol-Induced Osteopenia and Changes in Bone Morphology in Female Mice.Alcohol Clin Exp Res. 2017 Jan;41(1):46-56. doi: 10.1111/acer.13284. Epub 2016 Dec 17. Alcohol Clin Exp Res. 2017. PMID: 27987315 Free PMC article.
-
Palm tocotrienol supplementation enhanced bone formation in oestrogen-deficient rats.Int J Endocrinol. 2012;2012:532862. doi: 10.1155/2012/532862. Epub 2012 Oct 22. Int J Endocrinol. 2012. PMID: 23150728 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases